Are you a patient with painful knee osteoarthritis below the age of 65 years? Return to your active life after a six weeks treatment with the KneeReviver.
The KneeReviver unloads the damaged knee joint by putting the knee joint surfaces on a short distance. With this temporary unloading treatment the knee joint tissues regenerate.
Patients diagnosed with knee osteoarthritis, not responding to conservative therapy, probably already indicated for a knee replacement, under the age of 65 years old.
This unloading treatment is studied in medical research groups for > 10 years, resulting in knee joint preservation, decrease of pain, increase of function, and postponing a knee replacement.
Postponing the need for total knee replacement,
avoiding complex revision surgery
- Consists of 2 tubes placed on both sides of the knee
- Is fixated to the bone by eight bone pins
- Unloads the knee joint by creating space between the joint surfaces
- It is allowed to bear weight during treatment, however it is not possible to bend the knee
The Knee Reviver is developed by ArthroSave, in collaboration with orthopaedic surgeons, researchers and patients. It is the only device with intended use for knee joint distraction.
Knee joint distraction is a joint preserving
surgical treatment with use of the KneeReviver
12 November 2021
Great news! We’ve been selected as a semifinalist in the EIT Health Catapult competition!
ArthroSave has been selected as a semifinalist in the EIT Health Catapult competition. Discover more about innovative projects for the healthcare industry. Don’t miss out on the semifinals event on 1-3 December 2021!
By taking part in the EIT Health Catapult, successful start-ups receive high-quality, bespoke training in business modelling and planning, investment deal negotiation and specialised pitch preparation, while gaining access to Europe’s top healthcare experts and investors. The start-ups receive intensive training as they build their credibility and visibility through pan-European exposure.
Finalists are showcased at the EIT Health Summit as they go head-to-head for their share of the €210,000 investment prize fund with the Audience Award Winner displayed on the New York Nasdaq Tower.
19 October 2021
Great news! We’ve been selected for the first edition of Pole Position!
We are so thrilled to have been selected for the first edition of Pole Position – an initiative tailored for ambitious deeptech companies who want to fasten their growth. This initiative will help us scale more efficiently by providing access to the best experts and network.